Commerzbank Aktiengesellschaft FI Sells 12,962 Shares of DENTSPLY SIRONA Inc (NASDAQ:XRAY)

Commerzbank Aktiengesellschaft FI reduced its position in shares of DENTSPLY SIRONA Inc (NASDAQ:XRAY) by 78.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 3,477 shares of the medical instruments supplier’s stock after selling 12,962 shares during the period. Commerzbank Aktiengesellschaft FI’s holdings in DENTSPLY SIRONA were worth $229,000 at the end of the most recent reporting period.

Several other institutional investors have also recently added to or reduced their stakes in XRAY. Ruane Cunniff & Goldfarb Inc. lifted its position in DENTSPLY SIRONA by 0.5% in the third quarter. Ruane Cunniff & Goldfarb Inc. now owns 8,890,655 shares of the medical instruments supplier’s stock valued at $531,750,000 after acquiring an additional 40,767 shares during the last quarter. Principal Financial Group Inc. increased its stake in DENTSPLY SIRONA by 6.7% in the third quarter. Principal Financial Group Inc. now owns 6,910,770 shares of the medical instruments supplier’s stock valued at $413,333,000 after purchasing an additional 436,338 shares during the period. Jackson Square Partners LLC increased its stake in DENTSPLY SIRONA by 15.6% in the third quarter. Jackson Square Partners LLC now owns 6,334,906 shares of the medical instruments supplier’s stock valued at $378,890,000 after purchasing an additional 855,199 shares during the period. Neuberger Berman Group LLC increased its stake in DENTSPLY SIRONA by 5.3% in the third quarter. Neuberger Berman Group LLC now owns 5,781,470 shares of the medical instruments supplier’s stock valued at $345,790,000 after purchasing an additional 292,505 shares during the period. Finally, Atlanta Capital Management Co. L L C increased its stake in DENTSPLY SIRONA by 0.6% in the third quarter. Atlanta Capital Management Co. L L C now owns 5,464,104 shares of the medical instruments supplier’s stock valued at $326,808,000 after purchasing an additional 33,162 shares during the period. 96.51% of the stock is owned by institutional investors and hedge funds.

Shares of DENTSPLY SIRONA Inc (NASDAQ:XRAY) traded up $0.19 during trading on Thursday, hitting $57.18. 1,836,800 shares of the stock were exchanged, compared to its average volume of 2,458,911. DENTSPLY SIRONA Inc has a twelve month low of $52.53 and a twelve month high of $68.98. The company has a current ratio of 2.32, a quick ratio of 1.59 and a debt-to-equity ratio of 0.21. The firm has a market capitalization of $13,089.63, a price-to-earnings ratio of -16.48, a price-to-earnings-growth ratio of 2.10 and a beta of 1.18.

The company also recently declared a quarterly dividend, which will be paid on Friday, April 13th. Stockholders of record on Thursday, March 29th will be paid a dividend of $0.0875 per share. This represents a $0.35 dividend on an annualized basis and a dividend yield of 0.61%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is -10.09%.

In other news, Director Eric Brandt sold 6,409 shares of the business’s stock in a transaction dated Monday, January 8th. The shares were sold at an average price of $68.04, for a total transaction of $436,068.36. Following the transaction, the director now directly owns 12,073 shares in the company, valued at $821,446.92. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 1.99% of the company’s stock.

A number of research analysts have commented on the stock. HC Wainwright lowered shares of DENTSPLY SIRONA from a “buy” rating to a “neutral” rating and set a $68.00 price objective on the stock. in a research note on Thursday, November 30th. Deutsche Bank assumed coverage on shares of DENTSPLY SIRONA in a research note on Friday, December 8th. They issued a “buy” rating and a $81.00 price objective on the stock. BidaskClub lowered shares of DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a research note on Tuesday, January 23rd. Barrington Research upgraded shares of DENTSPLY SIRONA from a “market perform” rating to an “outperform” rating and set a $73.00 price objective on the stock in a research note on Monday, November 6th. Finally, Zacks Investment Research lowered shares of DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a research note on Monday, January 8th. Three analysts have rated the stock with a sell rating, four have issued a hold rating and eight have issued a buy rating to the stock. The company has an average rating of “Hold” and an average price target of $69.15.

COPYRIGHT VIOLATION NOTICE: This report was published by Week Herald and is the sole property of of Week Herald. If you are accessing this report on another domain, it was stolen and reposted in violation of U.S. and international copyright and trademark laws. The correct version of this report can be accessed at https://weekherald.com/2018/02/15/commerzbank-aktiengesellschaft-fi-sells-12962-shares-of-dentsply-sirona-inc-xray.html.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply